Edition:
United Kingdom

NantHealth Inc (NH.OQ)

NH.OQ on NASDAQ Stock Exchange Global Select Market

3.30USD
22 Jun 2018
Change (% chg)

$0.20 (+6.45%)
Prev Close
$3.10
Open
$3.15
Day's High
$3.30
Day's Low
$3.13
Volume
376,502
Avg. Vol
27,357
52-wk High
$5.25
52-wk Low
$2.60

Latest Key Developments (Source: Significant Developments)

NantHealth reports 2017 third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Nanthealth Inc :NantHealth reports 2017 third quarter financial results; GPS revenue doubles from preceding quarter.Q3 adjusted non-GAAP loss per share $0.13 from continuing operations.Q3 loss per share $0.20 from continuing operations.Q3 loss per share $0.37.Q3 revenue $21.8 million versus $20.7 million.Q3 revenue view $29.2 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S.NantHealth Inc - ‍ restructuring plan was initiated in Q3, plan expected to generate annualized cost savings of more than $70 million​.  Full Article

Nanthealth reports strong 2016 Q2 revenues and continued progress on GPS Cancer and nantos platform
Tuesday, 9 Aug 2016 

Nanthealth Reports Strong 2016 Second : Q2 adjusted non-GAAP loss per share $0.15 . Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.52 . Quarter revenues and continued progress on GPS Cancer and nantos platform . Q2 revenue rose 167 percent to $31.5 million .Q2 revenue view $23.5 million -- Thomson Reuters I/B/E/S.  Full Article

Photo

Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO

LOS ANGELES Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuters.